Atlas Lithium Corporation — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023; filed March 27, 2024. Although the request identifies 2023 Q4, this filing reports annual results, not standalone fourth-quarter results. Atlas Lithium is an exploration and development company focused on hard-rock lithium in Minas Gerais, Brazil; it had not begun commercial lithium production.
Business context and project status
- The principal asset is the Minas Gerais Lithium Project, including the Neves Project. Atlas reported 85 Minas Gerais lithium mineral rights covering approximately 468 km² and 72,899 meters drilled at Neves through year-end. Four spodumene-bearing pegmatites, Anitta 1–4, had been identified; the company reported no mineral reserves.
- Atlas was developing a modular dense-media-separation plant, targeting Phase I capacity of 150,000 tonnes of concentrate annually and a possible Phase II expansion to 300,000 tonnes annually. The stated estimated capital cost for initial production and ramp-up was $49.5 million.
- The company also holds exploration interests in other battery minerals and consolidates Apollo Resources and Jupiter Gold in its financial statements. Its reported revenue was not from lithium production.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $0 | $6,765 |
| Operating expenses | $42.59 million | $5.45 million |
| Net loss attributable to Atlas shareholders | $41.39 million | $4.63 million |
| Basic and diluted loss per share | $4.11 | $1.00 |
| Cash used in operating activities | $5.03 million | $1.48 million |
| Cash used in investing activities | $7.08 million | $2.85 million |
| Cash provided by financing activities | $41.21 million | $4.50 million |
- Revenue and gross margin are not meaningful indicators of ongoing operations: 2022 revenue came from industrial sand, a business line discontinued in December 2022. There was no 2023 revenue.
- Operating expenses rose 682%. Major components were exploration expense of $16.55 million, stock-based compensation of $15.61 million, and general and administrative expense of $10.30 million. Management attributed the exploration increase to the lithium drilling program and the compensation increase mainly to the higher share price and awards to new management.
- At December 31, 2023, cash and cash equivalents were $29.55 million, versus $0.28 million a year earlier; working capital was $24.04 million, compared with a $2.45 million deficit. Management said available cash was expected to cover working capital and capital expenditures for at least 12 months through March 2025, while noting that further financing may be needed.
- Total assets were $43.68 million, total liabilities $34.37 million, and stockholders’ equity $9.31 million. The balance sheet included $9.77 million of convertible debt, reported net of discount, and $1.00 million of derivative liabilities. The company issued $10 million principal amount of 6.5% convertible notes in 2023; the notes mature in 2026 and are convertible at $28.225 per share. A separate agreement allowed for up to $20 million of note proceeds.
- Debt and liquidity should be considered alongside the $18.60 million year-end deferred consideration liability related to the royalty sale. The company received $20 million cash for a 3% gross-revenue royalty on certain properties. The cash flow statement includes $20 million from this transaction in its operating-activities reconciliation.
Material changes, outlook, risks and unusual items
- Funding and dilution: Financing activities included equity issuance and the convertible notes. Common shares outstanding increased from 5.11 million at year-end 2022 to 12.76 million at year-end 2023. The company also sold a 3% royalty interest for $20 million, reducing its future revenue from the covered properties.
- Offtake agreements: In November 2023, Atlas agreed to sell each of two buyers 60,000 dry metric tonnes of lithium concentrate annually for five years, subject to a potential 10% annual quantity adjustment. Each buyer agreed to invest $5 million in common stock and, after permits, provide a further $20 million as a prepayment for future deliveries. These amounts and sales depend on permitting, production, and the agreements’ terms.
- Production plans: Subsequent to year-end, Atlas said plant-module delivery to Brazil was expected in Q2 2024 and initial commissioning and production were targeted for Q4 2024, with Phase II targeted for mid-2025. These are company targets, not assurances; the filing cautions that funding, permitting, construction, commissioning, product quality, and production capacity could prevent or delay them.
- Exploration evidence: Metallurgical testing on a representative sample reported concentrate grading 6.04% Li₂O, 0.53% Fe₂O₃, and 70% lithium recovery using dense media separation. This test result does not establish commercial-scale recoveries or project economics. The company had engaged SGS to prepare a maiden mineral resource report; no resource estimate or reserve was reported in this filing.
- Major risks: The company has a history of losses, no material operating revenue, and no reserves. Its plans depend on exploration success, additional capital, permits, execution of plant construction, lithium prices and demand, and Brazilian regulatory and currency conditions. Atlas reported lithium prices fell substantially during 2023 and identified price volatility as a risk.
- Governance and controls: CEO Marc Fogassa held the Series A preferred share carrying 51% of total voting power; the filing reported approximately 68.1% voting power as of year-end 2023. Management concluded disclosure controls and internal control over financial reporting were effective at a reasonable-assurance level. The auditor did not attest to internal controls, and the financial statement audit reported no critical audit matters.
Most important facts for investors to verify
- Current cash, remaining plant and mine-development costs, and whether additional financing is required to reach production.
- Status of required environmental, operating, and other permits; timing and conditions for the buyers’ contingent $20 million prepayments each.
- Progress against plant delivery, commissioning, production, capacity, and the $49.5 million capital estimate.
- Publication and assumptions of the maiden resource report and any subsequent economic study; distinguish drill intercepts and sample tests from proven resources, reserves, and commercial-scale results.
- Terms, security, conversion and dilution implications of the convertible notes, and the accounting and future payment effects of the royalty transaction.
- Whether the two offtake agreements can be fulfilled at planned volumes and on economically attractive pricing terms amid lithium-market volatility.